Collplant Holdings Ltd Sponsored ADR CLGN 深 滬
交易中 09-20 10:44:58 美东时间
4.986
+0.266
+5.64%
華盛通- 最 高5.00
- 今 開4.76
- 成交量 1301股
- 最 低 4.76
- 昨 收 4.72
- 總市值 5710.32万
- 52周最高 6.99
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 4.10
- 委 比 -92.00%
- 總股本 1145.27万
- 歷史最高 24.26
- 量 比 1.86
- 振 幅 5.08%
- 歷史最低 3.13
- 每 手 1
- 風險率 0.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Throughout the last three months, 4 analysts have evaluated CollPlant Biotechno...
08-21 22:00
CollPlant Announces Upcoming Shareholder Meeting
Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies Ltd...
08-21 04:47
CollPlant Pursues $3B Market with 3D-Printed Implants
Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies has...
08-20 19:27
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
REHOVOT, Israel, July 29, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based ...
07-29 19:00
Collplant Biotechnologies Ltd.2023财年实现净利润-7.02百万美元，同比增加58.54%
12月31日，Collplant Biotechnologies Ltd.（CLGN.US）公布财报，公告显示公司2023财年净利润为-7.02百万美元，同比增...
04-05 15:12
CollPlant Biotechnologies GAAP EPS of -$0.62, revenue of $10.96M
CollPlant Biotechnologies press release (NASDAQ:CLGN): FY GAAP EPS of -$0.62. Revenue of $10.96M. More on CollPlant Biotechnologies Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical...
04-04 19:05
Earnings Scheduled For April 4, 2024
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.
04-04 17:18
CollPlant Issues Letter to Shareholders
REHOVOT, Israel, Feb. 15, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...
02-15 21:00
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ
01-02 20:11
Recap: CollPlant Biotechnologies Q3 Earnings
CollPlant Biotechnologies (NASDAQ:CLGN) reported its Q3 earnings results on Wed...
2023-11-29 20:10
